PRESS RELEASE published on 09/18/2024 at 07:56, 1 year 5 months ago Cancellation of remaining publicly held registered shares of Crealogix Holding AG and suspension of trading Crealogix Holding AG announces cancellation of remaining shares and suspension of trading, with compensation of CHF 60 per share. Delisting date set for 8 November 2024 on SIX Swiss Exchange Compensation CREALOGIX Holding AG Cancellation Delisting SIX Swiss Exchange
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago UKA places order with Nordex Group for 68 MW of N175/6.X turbines in Germany UKA orders 10 N175/6.X turbines from Nordex Group for 68 MW Mahlsdorf wind farm in Germany, breaking 70 GW global order intake mark. First N175/6.X turbines with 179m hub height Germany Nordex Group Wind Farm UKA N175/6.X Turbines
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago DEMIRE lets around 1,900 m² to FrontWell in Bad Vilbel DEMIRE Deutsche Mittelstand Real Estate AG lets around 1,900 m² to FrontWell Solutions in Bad Vilbel, expanding its property with good accessibility and stable rental income Real Estate Property Development DEMIRE Bad Vilbel FrontWell Solutions
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago Nicox Announces Approval of ZERVIATE in China Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration China Approval Nicox ZERVIATE Ocular Itching
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago Nicox annonce l’approbation de ZERVIATE en Chine Nicox annonce l’approbation de ZERVIATE, solution ophtalmique de cétirizine, pour le prurit oculaire en Chine, avec Ocumension Therapeutics. Nouvelle source de revenus pour Nicox Chine Nicox Ocumension Therapeutics ZERVIATE Prurit Oculaire
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 5 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel Sensorion publie ses résultats du premier semestre 2024 et fait le point sur ses activités. Premières données cliniques de SENS-501 et SENS-401 au Congrès Mondial d'Audiologie Résultats Premier Semestre Audiologie Sensorion Clinique
PRESS RELEASE published on 09/18/2024 at 07:14, 1 year 5 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
PRESS RELEASE published on 09/18/2024 at 07:14, 1 year 5 months ago Inside Information / Operations of the issuer (acquisitions, sales...) CARMAT launches a capital increase of €10.3 million, extendable up to €13.6 million, with a subscription price of €1.60 per share to fund activities until at least 2024. Offering includes priority period for shareholders and global placement Financial Structure Capital Increase Subscription Price CARMAT Global Placement
PRESS RELEASE published on 09/18/2024 at 07:00, 1 year 5 months ago Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Relief Therapeutics completes clinical phase in RLF-OD032 proof-of-concept study for PKU treatment, expecting topline results in October 2024 Relief Therapeutics RLF-OD032 Proof-of-Concept Study PKU Treatment Topline Results
Published on 02/21/2026 at 00:45, 7 hours 38 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 7 hours 53 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 9 hours 23 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 10 hours 6 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/20/2026 at 18:36, 13 hours 46 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 13 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 14 hours 22 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 14 hours 22 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 12 hours 53 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 12 hours 53 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 14 hours 23 minutes ago TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 14 hours 23 minutes ago TERACT - Résiliation du contrat de liquidité